Buyout Firms Eye Wockhardt’s Domestic Formulations Unit

Wockhardt
Private-Equity Firms Have Their Eye On Wockhardt • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business